FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

SUPPL AP for SEROQUEL (QUETIAPINE)